Oral administration of the 11β-hydroxysteroid-dehydrogenase type 1 inhibitor RO5093151 to patients with glaucoma: an adaptive, randomised, placebo-controlled clinical study
Dietmar Schwab, Carolina Sturm, Agnès Portron, Sabine Fuerst-Recktenwald, Dominik Hainzl, Paul Jordan, William C Stewart, Michael E Tepedino, Harvey DuBiner
BMJ Open Ophthalmology Jun 2017, 1 (1) e000063; DOI: 10.1136/bmjophth-2016-000063
